Open Therapeutics
PrivateLast Round
Grant
Nov 8, 2022
Company Overview
Open Therapeutics is a biotechnology company that curates and develops open-source medical, biopharma, and synthetic biology-based technologies for the global scientific community.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Blockchain Infrastructure, Tokenization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Open Therapeutics Comparables
Compare Open Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResearchHub | 83% | |
| Open Source Pharma Foundation | 82% | |
| Etica Protocol | 77% | |
Open Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 8, 2022 | ||||
| Early Funding | Feb 19, 2019 |
Open Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Timmaron Group | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2022
Received grant funding.
- Feb 19, 2019
Raised capital with participation from Timmaron Group.
Open Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Open Therapeutics's valuation, stock price, and market status.